Sight Sciences Receives FDA Clearance for Expanded Indication for OMNI Surgical System
OMNI is the first microinvasive glaucoma surgery (MIGS) device indicated to lower IOP in adult patients
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Mar 21
OMNI is the first microinvasive glaucoma surgery (MIGS) device indicated to lower IOP in adult patients
Scientists from the University of Illinois at Chicago believe their newly developed 4D materials are 'excellent candidates' for…
03 Mar 21
Agreement extends research and clinical development across ViaCyte's full product portfolio and Gore's full materials and device proprietary…
01 Mar 21
University of Colorado Boulder researchers revealed the mechanism by which cell adhesion takes place in the body
26 Feb 21
The 510(k) approval means Fusion Robotics will now be able to market its product that assists in spinal…
Chondro3 has been recognised by the FDA Breakthrough Devices Program, which aims to improve patient access to new…
23 Feb 21
A team of researchers from Korea and the US recorded promising results in an early muscle tissue regeneration…
23 Feb 21
Twist Bioscience is a rapidly growing synthetic biology and genomics company developing disruptive DNA synthesis platform
Potential applications of MIT's new superconducting nanowire innovation include uses in the electronics of medical imaging systems and…
The Medical Tubing and Catheters event is set to take place virtually from 2-4 March 2021, and will…